Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 683 entries
Sorted by: Best Match Show Resources per page
Lessons from WINGS.

Diabetes research and clinical practice

Malanda B.
PMID: 29223254
Diabetes Res Clin Pract. 2017 Dec;134:210-211. doi: 10.1016/j.diabres.2017.11.017.

No abstract available.

Cite
Malanda B. Lessons from WINGS. Diabetes Res Clin Pract. 2017;134:210-211doi: 10.1016/j.diabres.2017.11.017.
Malanda, B. (2017). Lessons from WINGS. Diabetes research and clinical practice, 134210-211. https://doi.org/10.1016/j.diabres.2017.11.017
Malanda, Belma. "Lessons from WINGS." Diabetes research and clinical practice vol. 134 (2017): 210-211. doi: https://doi.org/10.1016/j.diabres.2017.11.017
Malanda B. Lessons from WINGS. Diabetes Res Clin Pract. 2017 Dec;134:210-211. doi: 10.1016/j.diabres.2017.11.017. PMID: 29223254.
Copy Download .nbib Format: NLM
Neurologic Outcomes Following Care in the Pediatric Intensive Care Unit.

Current treatment options in pediatrics

Caprarola SD, Kudchadkar SR, Bembea MM.
PMID: 29218262
Curr Treat Options Pediatr. 2017 Sep;3(3):193-207. doi: 10.1007/s40746-017-0092-x. Epub 2017 Jul 26.

PURPOSE OF REVIEW: With increasing survival of children requiring admission to pediatric intensive care units (PICU), neurodevelopmental outcomes of these patients are an area of increased attention. Our goal was to systematically review recently published literature on neurologic outcomes...

Cite
Caprarola SD, Kudchadkar SR, Bembea MM. Neurologic Outcomes Following Care in the Pediatric Intensive Care Unit. Curr Treat Options Pediatr. 2017;3(3):193-207doi: 10.1007/s40746-017-0092-x.
Caprarola, S. D., Kudchadkar, S. R., & Bembea, M. M. (2017). Neurologic Outcomes Following Care in the Pediatric Intensive Care Unit. Current treatment options in pediatrics, 3(3), 193-207. https://doi.org/10.1007/s40746-017-0092-x
Caprarola, Sherrill D, et al. "Neurologic Outcomes Following Care in the Pediatric Intensive Care Unit." Current treatment options in pediatrics vol. 3,3 (2017): 193-207. doi: https://doi.org/10.1007/s40746-017-0092-x
Caprarola SD, Kudchadkar SR, Bembea MM. Neurologic Outcomes Following Care in the Pediatric Intensive Care Unit. Curr Treat Options Pediatr. 2017 Sep;3(3):193-207. doi: 10.1007/s40746-017-0092-x. Epub 2017 Jul 26. PMID: 29218262; PMCID: PMC5714514.
Copy Download .nbib Format: NLM
Comment on the Article "Dietary Supplements for Improving Body Composition and Reducing Body Weight: Where Is the Evidence?" and Reply from the Author.

International journal of sport nutrition and exercise metabolism

Manore MM.
PMID: 29160757
Int J Sport Nutr Exerc Metab. 2012 Dec;22(6):407-411. doi: 10.1123/ijsnem.22.6.407.

No abstract available.

Cite
Manore MM. Comment on the Article "Dietary Supplements for Improving Body Composition and Reducing Body Weight: Where Is the Evidence?" and Reply from the Author. Int J Sport Nutr Exerc Metab. 2012;22(6):407-411doi: 10.1123/ijsnem.22.6.407.
Manore, M. M. (2012). Comment on the Article "Dietary Supplements for Improving Body Composition and Reducing Body Weight: Where Is the Evidence?" and Reply from the Author. International journal of sport nutrition and exercise metabolism, 22(6), 407-411. https://doi.org/10.1123/ijsnem.22.6.407
Manore, Melinda M. "Comment on the Article "Dietary Supplements for Improving Body Composition and Reducing Body Weight: Where Is the Evidence?" and Reply from the Author." International journal of sport nutrition and exercise metabolism vol. 22,6 (2012): 407-411. doi: https://doi.org/10.1123/ijsnem.22.6.407
Manore MM. Comment on the Article "Dietary Supplements for Improving Body Composition and Reducing Body Weight: Where Is the Evidence?" and Reply from the Author. Int J Sport Nutr Exerc Metab. 2012 Dec;22(6):407-411. doi: 10.1123/ijsnem.22.6.407. PMID: 29160757.
Copy Download .nbib Format: NLM
The genomic tool-kit of the truffle .

Cell death discovery

Zarivi O, Cesare P, Poma AM, Colafarina S, Bonfigli A, Kohler A, Aimola P, Ragnelli AM, Pacioni G, Miranda M.
PMID: 29531829
Cell Death Discov. 2018 Feb 20;4:32. doi: 10.1038/s41420-017-0019-0. eCollection 2018 Dec.

A survey of the truffle

Cite
Zarivi O, Cesare P, Poma AM, et al. The genomic tool-kit of the truffle . Cell Death Discov. 2018;4:32doi: 10.1038/s41420-017-0019-0.
Zarivi, O., Cesare, P., Poma, A. M., Colafarina, S., Bonfigli, A., Kohler, A., Aimola, P., Ragnelli, A. M., Pacioni, G., & Miranda, M. (2018). The genomic tool-kit of the truffle . Cell death discovery, 432. https://doi.org/10.1038/s41420-017-0019-0
Zarivi, Osvaldo, et al. "The genomic tool-kit of the truffle ." Cell death discovery vol. 4 (2018): 32. doi: https://doi.org/10.1038/s41420-017-0019-0
Zarivi O, Cesare P, Poma AM, Colafarina S, Bonfigli A, Kohler A, Aimola P, Ragnelli AM, Pacioni G, Miranda M. The genomic tool-kit of the truffle . Cell Death Discov. 2018 Feb 20;4:32. doi: 10.1038/s41420-017-0019-0. eCollection 2018 Dec. PMID: 29531829; PMCID: PMC5841409.
Copy Download .nbib Format: NLM
Sternal wound infections following cardiac surgery and their management: a single-centre study from the years 2016-2017.

Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery

Kotnis-Gąska A, Mazur P, Olechowska-Jarząb A, Stanisz A, Bulanda M, Undas A.
PMID: 30069187
Kardiochir Torakochirurgia Pol. 2018 Jun;15(2):79-85. doi: 10.5114/kitp.2018.76472. Epub 2018 Jun 25.

INTRODUCTION: Despite improvements in surgical management, sternal wound infection (SWI) following cardiac surgery remains a significant complication.AIM: To evaluate pathogens involved in SWI following median sternotomy.MATERIAL AND METHODS: We enrolled 164 patients who experienced prolonged sternal wound healing following...

Cite
Kotnis-Gąska A, Mazur P, Olechowska-Jarząb A, et al. Sternal wound infections following cardiac surgery and their management: a single-centre study from the years 2016-2017. Kardiochir Torakochirurgia Pol. 2018;15(2):79-85doi: 10.5114/kitp.2018.76472.
Kotnis-Gąska, A., Mazur, P., Olechowska-Jarząb, A., Stanisz, A., Bulanda, M., & Undas, A. (2018). Sternal wound infections following cardiac surgery and their management: a single-centre study from the years 2016-2017. Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery, 15(2), 79-85. https://doi.org/10.5114/kitp.2018.76472
Kotnis-Gąska, Agnieszka, et al. "Sternal wound infections following cardiac surgery and their management: a single-centre study from the years 2016-2017." Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery vol. 15,2 (2018): 79-85. doi: https://doi.org/10.5114/kitp.2018.76472
Kotnis-Gąska A, Mazur P, Olechowska-Jarząb A, Stanisz A, Bulanda M, Undas A. Sternal wound infections following cardiac surgery and their management: a single-centre study from the years 2016-2017. Kardiochir Torakochirurgia Pol. 2018 Jun;15(2):79-85. doi: 10.5114/kitp.2018.76472. Epub 2018 Jun 25. PMID: 30069187; PMCID: PMC6066679.
Copy Download .nbib Format: NLM
Ion dehydration controls adsorption at the micellar interface: hydrotropic ions.

Physical chemistry chemical physics : PCCP

Lima FS, Andrade MFC, Mortara L, Gustavo Dias L, Cuccovia IM, Chaimovich H.
PMID: 29119186
Phys Chem Chem Phys. 2017 Nov 22;19(45):30658-30666. doi: 10.1039/c7cp05283a.

The properties of ionic micelles depend on the nature of the counterion, and these effects become more evident as the ion adsorption at the interface increases. Prediction of the relative extent of ion adsorption is required for rational design...

Cite
Lima FS, Andrade MFC, Mortara L, et al. Ion dehydration controls adsorption at the micellar interface: hydrotropic ions. Phys Chem Chem Phys. 2017;19(45):30658-30666doi: 10.1039/c7cp05283a.
Lima, F. S., Andrade, M. F. C., Mortara, L., Gustavo Dias, L., Cuccovia, I. M., & Chaimovich, H. (2017). Ion dehydration controls adsorption at the micellar interface: hydrotropic ions. Physical chemistry chemical physics : PCCP, 19(45), 30658-30666. https://doi.org/10.1039/c7cp05283a
Lima, Filipe S, et al. "Ion dehydration controls adsorption at the micellar interface: hydrotropic ions." Physical chemistry chemical physics : PCCP vol. 19,45 (2017): 30658-30666. doi: https://doi.org/10.1039/c7cp05283a
Lima FS, Andrade MFC, Mortara L, Gustavo Dias L, Cuccovia IM, Chaimovich H. Ion dehydration controls adsorption at the micellar interface: hydrotropic ions. Phys Chem Chem Phys. 2017 Nov 22;19(45):30658-30666. doi: 10.1039/c7cp05283a. PMID: 29119186.
Copy Download .nbib Format: NLM
Unknown risks to soil biodiversity from commercial fungal inoculants.

Nature ecology & evolution

Hart MM, Antunes PM, Abbott LK.
PMID: 28812666
Nat Ecol Evol. 2017 Mar 23;1(4):115. doi: 10.1038/s41559-017-0115.

No abstract available.

Cite
Hart MM, Antunes PM, Abbott LK. Unknown risks to soil biodiversity from commercial fungal inoculants. Nat Ecol Evol. 2017;1(4):115doi: 10.1038/s41559-017-0115.
Hart, M. M., Antunes, P. M., & Abbott, L. K. (2017). Unknown risks to soil biodiversity from commercial fungal inoculants. Nature ecology & evolution, 1(4), 115. https://doi.org/10.1038/s41559-017-0115
Hart, Miranda M, et al. "Unknown risks to soil biodiversity from commercial fungal inoculants." Nature ecology & evolution vol. 1,4 (2017): 115. doi: https://doi.org/10.1038/s41559-017-0115
Hart MM, Antunes PM, Abbott LK. Unknown risks to soil biodiversity from commercial fungal inoculants. Nat Ecol Evol. 2017 Mar 23;1(4):115. doi: 10.1038/s41559-017-0115. PMID: 28812666.
Copy Download .nbib Format: NLM
Lipoic Acid and Progesterone Alone or in Combination Ameliorate Retinal Degeneration in an Experimental Model of Hereditary Retinal Degeneration.

Frontiers in pharmacology

Ramírez-Lamelas DT, Benlloch-Navarro S, López-Pedrajas R, Gimeno-Hernández R, Olivar T, Silvestre D, Miranda M.
PMID: 29867476
Front Pharmacol. 2018 May 09;9:469. doi: 10.3389/fphar.2018.00469. eCollection 2018.

Retinitis pigmentosa (RP) is a group of inherited retinopathies characterized by photoreceptors death. Our group has shown the positive progesterone (P4) actions on cell death progression in an experimental model of RP. In an effort to enhance the beneficial...

Cite
Ramírez-Lamelas DT, Benlloch-Navarro S, López-Pedrajas R, et al. Lipoic Acid and Progesterone Alone or in Combination Ameliorate Retinal Degeneration in an Experimental Model of Hereditary Retinal Degeneration. Front Pharmacol. 2018;9:469doi: 10.3389/fphar.2018.00469.
Ramírez-Lamelas, D. T., Benlloch-Navarro, S., López-Pedrajas, R., Gimeno-Hernández, R., Olivar, T., Silvestre, D., & Miranda, M. (2018). Lipoic Acid and Progesterone Alone or in Combination Ameliorate Retinal Degeneration in an Experimental Model of Hereditary Retinal Degeneration. Frontiers in pharmacology, 9469. https://doi.org/10.3389/fphar.2018.00469
Ramírez-Lamelas, Dolores T, et al. "Lipoic Acid and Progesterone Alone or in Combination Ameliorate Retinal Degeneration in an Experimental Model of Hereditary Retinal Degeneration." Frontiers in pharmacology vol. 9 (2018): 469. doi: https://doi.org/10.3389/fphar.2018.00469
Ramírez-Lamelas DT, Benlloch-Navarro S, López-Pedrajas R, Gimeno-Hernández R, Olivar T, Silvestre D, Miranda M. Lipoic Acid and Progesterone Alone or in Combination Ameliorate Retinal Degeneration in an Experimental Model of Hereditary Retinal Degeneration. Front Pharmacol. 2018 May 09;9:469. doi: 10.3389/fphar.2018.00469. eCollection 2018. PMID: 29867476; PMCID: PMC5954235.
Copy Download .nbib Format: NLM
Metagenomic Analysis of Duodenal Microbiota Reveals a Potential Biomarker of Dysbiosis in the Course of Obesity and Type 2 Diabetes: A Pilot Study.

Journal of clinical medicine

Sroka-Oleksiak A, Młodzińska A, Bulanda M, Salamon D, Major P, Stanek M, Gosiewski T.
PMID: 32013181
J Clin Med. 2020 Jan 29;9(2). doi: 10.3390/jcm9020369.

Numerous scientific studies confirm that, apart from environmental and genetic factors, a significant role is played by gastrointestinal microbiota in the aetiology of type 2 diabetes and obesity. Currently, scientists mainly focus on the distal intestinal microbiota, while the...

Cite
Sroka-Oleksiak A, Młodzińska A, Bulanda M, et al. Metagenomic Analysis of Duodenal Microbiota Reveals a Potential Biomarker of Dysbiosis in the Course of Obesity and Type 2 Diabetes: A Pilot Study. J Clin Med. 2020;9(2)doi: 10.3390/jcm9020369.
Sroka-Oleksiak, A., Młodzińska, A., Bulanda, M., Salamon, D., Major, P., Stanek, M., & Gosiewski, T. (2020). Metagenomic Analysis of Duodenal Microbiota Reveals a Potential Biomarker of Dysbiosis in the Course of Obesity and Type 2 Diabetes: A Pilot Study. Journal of clinical medicine, 9(2), . https://doi.org/10.3390/jcm9020369
Sroka-Oleksiak, Agnieszka, et al. "Metagenomic Analysis of Duodenal Microbiota Reveals a Potential Biomarker of Dysbiosis in the Course of Obesity and Type 2 Diabetes: A Pilot Study." Journal of clinical medicine vol. 9,2 (2020). doi: https://doi.org/10.3390/jcm9020369
Sroka-Oleksiak A, Młodzińska A, Bulanda M, Salamon D, Major P, Stanek M, Gosiewski T. Metagenomic Analysis of Duodenal Microbiota Reveals a Potential Biomarker of Dysbiosis in the Course of Obesity and Type 2 Diabetes: A Pilot Study. J Clin Med. 2020 Jan 29;9(2). doi: 10.3390/jcm9020369. PMID: 32013181; PMCID: PMC7074165.
Copy Download .nbib Format: NLM
Inpatient Management of Uncomplicated Skin and Soft Tissue Infections in 34 Veterans Affairs Medical Centers: A Medication Use Evaluation.

Open forum infectious diseases

Sutton JD, Carico R, Burk M, Jones MM, Wei X, Neuhauser MM, Goetz MB, Echevarria KL, Spivak ES, Cunningham FE.
PMID: 32010738
Open Forum Infect Dis. 2020 Jan 27;7(1):ofz554. doi: 10.1093/ofid/ofz554. eCollection 2020 Jan.

BACKGROUND: Skin and soft tissue infections (SSTIs) are a key antimicrobial stewardship target because they are a common infection in hospitalized patients, and non-guideline-concordant antibiotic use is frequent. To inform antimicrobial stewardship interventions, we evaluated the proportion of veterans...

Cite
Sutton JD, Carico R, Burk M, et al. Inpatient Management of Uncomplicated Skin and Soft Tissue Infections in 34 Veterans Affairs Medical Centers: A Medication Use Evaluation. Open Forum Infect Dis. 2020;7(1):ofz554doi: 10.1093/ofid/ofz554.
Sutton, J. D., Carico, R., Burk, M., Jones, M. M., Wei, X., Neuhauser, M. M., Goetz, M. B., Echevarria, K. L., Spivak, E. S., Cunningham, F. E. (2020). Inpatient Management of Uncomplicated Skin and Soft Tissue Infections in 34 Veterans Affairs Medical Centers: A Medication Use Evaluation. Open forum infectious diseases, 7(1), ofz554. https://doi.org/10.1093/ofid/ofz554
Sutton, Jesse D, et al. "Inpatient Management of Uncomplicated Skin and Soft Tissue Infections in 34 Veterans Affairs Medical Centers: A Medication Use Evaluation." Open forum infectious diseases vol. 7,1 (2020): ofz554. doi: https://doi.org/10.1093/ofid/ofz554
Sutton JD, Carico R, Burk M, Jones MM, Wei X, Neuhauser MM, Goetz MB, Echevarria KL, Spivak ES, Cunningham FE. Inpatient Management of Uncomplicated Skin and Soft Tissue Infections in 34 Veterans Affairs Medical Centers: A Medication Use Evaluation. Open Forum Infect Dis. 2020 Jan 27;7(1):ofz554. doi: 10.1093/ofid/ofz554. eCollection 2020 Jan. PMID: 32010738; PMCID: PMC6984672.
Copy Download .nbib Format: NLM
Safety evaluation of food enzyme glucan 1,4-α-maltohydrolase produced with a genetically modified .

EFSA journal. European Food Safety Authority

, Silano V, Bolognesi C, Castle L, Chipman K, Cravedi JP, Fowler P, Franz R, Grob K, Gürtler R, Husøy T, Kärenlampi S, Mennes W, Milana MR, Pfaff K, Riviere G, Srinivasan J, Tavares Poças MF, Tlustos C, Wölfle D, Zorn H, Herman L, Jany KD, Marcon F, Penninks A, Smith A, Arcella D, Gomes A, Kovalkovičová N, Liu Y, Maia J, Engel KH.
PMID: 32625890
EFSA J. 2018 May 02;16(5):e05168. doi: 10.2903/j.efsa.2018.5168. eCollection 2018 May.

The food enzyme considered in this opinion is a glucan 1,4-α-maltohydrolase (maltogenic α-amylase; EC 3.2.1.133) produced with the genetically modified

Cite
, Silano V, Bolognesi C, et al. Safety evaluation of food enzyme glucan 1,4-α-maltohydrolase produced with a genetically modified . EFSA J. 2018;16(5):e05168doi: 10.2903/j.efsa.2018.5168.
, Silano, V., Bolognesi, C., Castle, L., Chipman, K., Cravedi, J. P., Fowler, P., Franz, R., Grob, K., Gürtler, R., Husøy, T., Kärenlampi, S., Mennes, W., Milana, M. R., Pfaff, K., Riviere, G., Srinivasan, J., Tavares Poças, M. F., Tlustos, C., Wölfle, D., Zorn, H., Herman, L., Jany, K. D., Marcon, F., Penninks, A., Smith, A., Arcella, D., Gomes, A., Kovalkovičová, N., Liu, Y., Maia, J., & Engel, K. H. (2018). Safety evaluation of food enzyme glucan 1,4-α-maltohydrolase produced with a genetically modified . EFSA journal. European Food Safety Authority, 16(5), e05168. https://doi.org/10.2903/j.efsa.2018.5168
, et al. "Safety evaluation of food enzyme glucan 1,4-α-maltohydrolase produced with a genetically modified ." EFSA journal. European Food Safety Authority vol. 16,5 (2018): e05168. doi: https://doi.org/10.2903/j.efsa.2018.5168
, Silano V, Bolognesi C, Castle L, Chipman K, Cravedi JP, Fowler P, Franz R, Grob K, Gürtler R, Husøy T, Kärenlampi S, Mennes W, Milana MR, Pfaff K, Riviere G, Srinivasan J, Tavares Poças MF, Tlustos C, Wölfle D, Zorn H, Herman L, Jany KD, Marcon F, Penninks A, Smith A, Arcella D, Gomes A, Kovalkovičová N, Liu Y, Maia J, Engel KH. Safety evaluation of food enzyme glucan 1,4-α-maltohydrolase produced with a genetically modified . EFSA J. 2018 May 02;16(5):e05168. doi: 10.2903/j.efsa.2018.5168. eCollection 2018 May. PMID: 32625890; PMCID: PMC7009641.
Copy Download .nbib Format: NLM
Safety evaluation of the food enzyme maltogenic amylase from a genetically modified .

EFSA journal. European Food Safety Authority

, Silano V, Bolognesi C, Castle L, Chipman K, Cravedi JP, Fowler P, Franz R, Grob K, Gürtler R, Husøy T, Kärenlampi S, Mennes W, Milana MR, Pfaff K, Riviere G, Srinivasan J, Tavares Poças MF, Tlustos C, Wölfle D, Zorn H, Chesson A, Glandorf B, Herman L, Jany KD, Marcon F, Penninks A, Smith A, van Loveren H, Želježic D, Aguilera-Gómez M, Andryszkiewicz M, Arcella D, Kovalkovičová N, Liu Y, Engel KH.
PMID: 32625893
EFSA J. 2018 May 02;16(5):e05171. doi: 10.2903/j.efsa.2018.5171. eCollection 2018 May.

The food enzyme considered is a maltogenic amylase (glucan 1,4-α-maltohydrolase; EC 3.2.1.133) produced with the genetically modified

Cite
, Silano V, Bolognesi C, et al. Safety evaluation of the food enzyme maltogenic amylase from a genetically modified . EFSA J. 2018;16(5):e05171doi: 10.2903/j.efsa.2018.5171.
, Silano, V., Bolognesi, C., Castle, L., Chipman, K., Cravedi, J. P., Fowler, P., Franz, R., Grob, K., Gürtler, R., Husøy, T., Kärenlampi, S., Mennes, W., Milana, M. R., Pfaff, K., Riviere, G., Srinivasan, J., Tavares Poças, M. F., Tlustos, C., Wölfle, D., Zorn, H., Chesson, A., Glandorf, B., Herman, L., Jany, K. D., Marcon, F., Penninks, A., Smith, A., van Loveren, H., Želježic, D., Aguilera-Gómez, M., Andryszkiewicz, M., Arcella, D., Kovalkovičová, N., Liu, Y., & Engel, K. H. (2018). Safety evaluation of the food enzyme maltogenic amylase from a genetically modified . EFSA journal. European Food Safety Authority, 16(5), e05171. https://doi.org/10.2903/j.efsa.2018.5171
, et al. "Safety evaluation of the food enzyme maltogenic amylase from a genetically modified ." EFSA journal. European Food Safety Authority vol. 16,5 (2018): e05171. doi: https://doi.org/10.2903/j.efsa.2018.5171
, Silano V, Bolognesi C, Castle L, Chipman K, Cravedi JP, Fowler P, Franz R, Grob K, Gürtler R, Husøy T, Kärenlampi S, Mennes W, Milana MR, Pfaff K, Riviere G, Srinivasan J, Tavares Poças MF, Tlustos C, Wölfle D, Zorn H, Chesson A, Glandorf B, Herman L, Jany KD, Marcon F, Penninks A, Smith A, van Loveren H, Želježic D, Aguilera-Gómez M, Andryszkiewicz M, Arcella D, Kovalkovičová N, Liu Y, Engel KH. Safety evaluation of the food enzyme maltogenic amylase from a genetically modified . EFSA J. 2018 May 02;16(5):e05171. doi: 10.2903/j.efsa.2018.5171. eCollection 2018 May. PMID: 32625893; PMCID: PMC7009382.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 683 entries